{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:49:46Z","timestamp":1780890586785,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003575.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:00:00Z","timestamp":1510358400000}}],"reference-count":54,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003575.pub6","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T21:45:56Z","timestamp":1510436756000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Interventions for treating collagenous colitis"],"prefix":"10.1002","volume":"2017","author":[{"given":"Tahir S","family":"Kafil","sequence":"first","affiliation":[{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran M","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrease H","family":"Patton","sequence":"additional","affiliation":[{"name":"University of Western Ontario; Schulich School of Medicine & Dentistry; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Chande","sequence":"additional","affiliation":[{"name":"London Health Sciences Centre - Victoria Hospital; Room E6-321A 800 Commissioners Road East London ON Canada N6A 5W9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John WD","family":"McDonald","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,11]]},"reference":[{"issue":"Suppl III A250","key":"10.1002\/14651858.CD003575.pub6-BIB0001|cit1","first-page":"966","article-title":"Budesonide in collagenous colitis: A prospective double blind placebo controlled trial with histologic follow-up","volume":"47","author":"Baert","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003575.pub6-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/gast.2002.30295","article-title":"Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up","volume":"122","author":"Baert","year":"2002","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD003575.pub6-BIB0003|cit3","first-page":"A154","article-title":"Expression of inducible nitric oxide synthase (iNOS) mRNA in colonic mucosa in collagenous colitis - Correlation to the histological and clinical activity and the effect of budesonide treatment","volume":"126","author":"Bonderup","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD003575.pub6-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.52.2.248","article-title":"Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis","volume":"52","author":"Bonderup","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD003575.pub6-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.52.2.248","article-title":"Budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial with morphometric analysis","volume":"52","author":"Bonderup","year":"2003","journal-title":"Gut"},{"issue":"10","key":"10.1002\/14651858.CD003575.pub6-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/01.meg.0000231747.83760.bd","article-title":"Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis","volume":"18","author":"Bonderup","year":"2006","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Bonderup O Hansen J Teglbjaerg P Christensen L Fallingborg J Long-term budesonide treatment of collagenous colitis - a randomized, double-blind, placebo-controlled trial United European Gastroenterology Week 2007 No. FP-247","DOI":"10.1136\/gut.2008.156513"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD003575.pub6-BIB0008|cit8","first-page":"A487","article-title":"Long-Term Budesonide Treatment of Collagenous Colitis - a Randomized, Double Blind, Placebo Controlled Trial","volume":"134","author":"Bonderup","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD003575.pub6-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/gut.2008.156513","article-title":"Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial","volume":"58","author":"Bonderup","year":"2009","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD003575.pub6-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1440-1746.2006.04511.x","article-title":"Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial","volume":"22","author":"Calabrese","year":"2007","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0011|cit11","first-page":"A880","article-title":"Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis","volume":"116","author":"Fine","year":"1999","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD003575.pub6-BIB0012|cit12","first-page":"A581","article-title":"Boswellia serrata extract for the treatment of collagenous colitis: a randomized double-blind, placebo-controlled, multicenter trial","volume":"128","author":"Madisch","year":"2005","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD003575.pub6-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00384-007-0364-1","article-title":"Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled multicenter trial","volume":"22","author":"Madisch","year":"2007","journal-title":"International Journal of Colorectal Disease"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00384-004-0660-y","article-title":"Oral budesonide therapy improves quality of life in patients with collagenous colitis","volume":"20","author":"Madisch","year":"2005","journal-title":"International Journal of Colorectal Disease"},{"issue":"4 Suppl. 1","key":"10.1002\/14651858.CD003575.pub6-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"A191","DOI":"10.1016\/S0016-5085(03)80959-9","article-title":"Oral budesonide therapy improves quality of life in patients with collagenous colitis-results of placebo-controlled, multicenter trial","volume":"124","author":"Madisch","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/gast.2002.36042","article-title":"Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"123","author":"Miehlke","year":"2002","journal-title":"Gastroenterology"},{"issue":"5 Suppl. 1","key":"10.1002\/14651858.CD003575.pub6-BIB0017|cit17","first-page":"A","article-title":"Oral budesonide is highly effective in the treatment of collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial","volume":"125","author":"Miehlke","year":"2001","journal-title":"Gastroenterology"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD003575.pub6-BIB0018|cit18","first-page":"A465","article-title":"Long-term follow-up and predictive factors for clinical relapse in patients with collagenous colitis after induction of remission with budesonide capsules","volume":"126","author":"Miehlke","year":"2004","journal-title":"Gastroenterology"},{"issue":"11-12","key":"10.1002\/14651858.CD003575.pub6-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-2036.2005.02688.x","article-title":"Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide","volume":"22","author":"Miehlke","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 Suppl. 1","key":"10.1002\/14651858.CD003575.pub6-BIB0020|cit20","first-page":"A488","article-title":"Oral budesonide or maintenance treatment of collagenous colitis: a randomised, placebo-controlled, double-blind trial","volume":"134","author":"Miehlke","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2008.07.081","article-title":"Oral budesonide for maintenance treatment of collagenous colitis: a randomized, placebo controlled, double-blind trial","volume":"135","author":"Miehlke","year":"2008","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD003575.pub6-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-0028-1089365","article-title":"Remission-maintaining therapy of collagenous colitis with Budesonide - a randomised, double-blind, placebo-controlled multi-centre study","volume":"46","author":"Miehlke","year":"2008","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Miehlke S Madisch A Bethke B Morgner A Kuhlish E Henker C Budesonide for maintenance treatment of collagenous colitis - a randomized, double-blind, placebo-controlled trial United European Gastroenterology Week 2007 No. PS-M-13","DOI":"10.1053\/j.gastro.2008.07.081"},{"issue":"5 (Suppl 1)","key":"10.1002\/14651858.CD003575.pub6-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S0016-5085(12)60791-4","article-title":"Double-blind, double-dummy, randomized, placebo-controlled, multicenter trial of budesonide and mesalamine in collagenous colitis","volume":"142","author":"Miehlke","year":"May 2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1053\/j.gastro.2014.01.019","article-title":"Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis","volume":"146","author":"Miehlke","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1016\/S1873-9946(13)60531-0","article-title":"European multicenter trial of budesonide and mesalazine for short-term treatment of active collagenous colitis (BUC60\/COC)","volume":"7","author":"Miehlke","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0027|cit27","unstructured":"Mohrbacher R Double-blind, double-dummy, randomized, placebo-controlled, multicenter trial of budesonide and mesalamine in collagenous colitis Email Correspondance"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1016\/S0016-5085(14)62125-9","article-title":"Clinical remission and quality of life in collagenous colitis: a one-year, randomised, placebo-controlled study with low-dose budesonide (BUC-63\/ COC)","volume":"146(5 suppl. 1)","author":"Munch","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0030|cit29","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1873-9946(14)60102-1","article-title":"Low-dose budesonide maintains clinical remission and quality of life in collagenous colitis over a one year period: results from the randomised, placebo-controlled BUC-63\/COC trial","volume":"8","author":"Munch","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0028|cit30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gutjnl-2014-308363","article-title":"Low-dose budesonide for maintenance of clinical remission in collagenous colitis: A randomised, placebo-controlled, 12-month trial","volume":"65","author":"M\u00fcnch","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD003575.pub6-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/00365520310002210","article-title":"Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study","volume":"38","author":"Munck","year":"2003","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD003575.pub6-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.MIB.0000218763.99334.49","article-title":"Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis","volume":"12","author":"Wildt","year":"2006","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0033|cit33","unstructured":"Wildt S Munck LK Vinther-Jensen L Hansen BF Nordgaard-Lassen I Christensen S Treatment of collagenous colitis with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. A randomised, double-blind, placebo-controlled trial United European Gastroenterology Week 2005 OP G-67"},{"issue":"3","key":"10.1002\/14651858.CD003575.pub6-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.crohns.2011.01.004","article-title":"Clinical course of microscopic colitis in a single-center cohort study","volume":"5","author":"Calabrese","year":"2011","journal-title":"Journal of Crohn's & Colitis"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000007516","article-title":"Budesonide in the treatment of collagenous colitis","volume":"59","author":"Delarive","year":"1998","journal-title":"Digestion"},{"issue":"2","key":"10.1002\/14651858.CD003575.pub6-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ajg.2012.416","article-title":"Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study","volume":"108","author":"Gentile","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S569","DOI":"10.14309\/00000434-201510001-01300","article-title":"Role of maintenance steroids in microscopic colitis","volume":"110","author":"Mali","year":"2015","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S1873-9946(14)60481-5","article-title":"Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy","volume":"8","author":"Miehlke","year":"2014","journal-title":"Journal of Crohn's & colitis"},{"issue":"5","key":"10.1002\/14651858.CD003575.pub6-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"S852","DOI":"10.1016\/S0016-5085(11)63537-3","article-title":"Evaluation of effects and complications of probiotics in microscopic colitis, a double blind placebo control clinical trial","volume":"140","author":"Taheri","year":"2011","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD003575.pub6-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006096.pub4","article-title":"Interventions for treating lymphocytic colitis","author":"Chande","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD003575.pub6-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199409293311303","article-title":"Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group","volume":"331","author":"Greenberg","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003575.pub6-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/gast.1996.v110.pm8536887","article-title":"Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group","volume":"110","author":"Greenberg","year":"1996","journal-title":"Gastroenterology"},{"issue":"7650","key":"10.1002\/14651858.CD003575.pub6-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0044|cit44","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD003575.pub6-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/ibd.20977","article-title":"Defining clinical criteria for clinical remission and disease activity in collagenous colitis","volume":"15","author":"Hjortswang","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD003575.pub6-BIB0046|cit46","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575","article-title":"Interventions for treating collagenous colitis","author":"Chande","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003575.pub6-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575","article-title":"Interventions for treating collagenous colitis","author":"Chande","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003575.pub6-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575","article-title":"Interventions for treating collagenous colitis","author":"Chande","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003575.pub6-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575.pub2","article-title":"Interventions for treating collagenous colitis","author":"Chande","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD003575.pub6-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1572-0241.2004.40917.x","article-title":"Interventions for treating collagenous colitis: A Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials","volume":"99","author":"Chande","year":"2004","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575.pub3","article-title":"Interventions for treating collagenous colitis","author":"Chande","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003575.pub6-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575.pub4","article-title":"Interventions for treating collagenous colitis","author":"Chande","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003575.pub6-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003575.pub5","article-title":"Interventions for treating lymphocytic colitis","author":"Chande","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003575.pub6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T18:54:47Z","timestamp":1686164087000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003575.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,11]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003575.pub6","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,11]]}}}